TrialVaccines2026

Immunogenicity and Safety of Extended Dosing Intervals for Pfizer Pentavalent MenABCWY Meningococcal Vaccination in Healthy Adolescents: Results from a Randomized, Phase 2b Study.

Jake C Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.